Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma

Fig. 2

Serum Egfl7 and AFP levels in the Validation Cohort. Serum Egfl7 (A) and AFP (B) levels in patients from the Validation Cohort with early HCC (n = 158), metastatic liver cancer (n = 12), benign liver tumors (n = 14), or chronic liver disease (n = 120), and healthy individuals (n = 172) were determined by ELISA. The horizontal lines in the figures represented means

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us